InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001724169-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-03 2026-03-01 ELAN VanHimbergen Robert M EVP, CFO A - Grant $0.00 +23.7K 148.7K +19% $0
D 2026-03-03 2026-03-01 ELAN VanHimbergen Robert M EVP, CFO A - Grant $0.00 +48.4K 48.4K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-01 A A 23,675 $0.00 148,652 D — — (F1) Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. (F2) Includes 744 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on January 31, 2026.
2 Derivative Employee Stock Option (right to buy) 2026-03-01 A A 48,375 $0.00 48,375 D $26.40 · — to 2036-03-01 48,375 Common Stock (F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.